Country Profile

Slovenia

Slovenia is a significant market for Indian pharmaceutical exports — $156M in FY 2025–26, with 2.4× growth over the past decade. Medicines accounts for 87% of shipments. The compound annual growth rate since FY2015 stands at 8.3%.

🇸🇮 $156M · 2.4× growth since FY2015 · 8.3% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$156M
Exports FY2025–26 DGCIS
2.4×
Growth FY2015→2026
8.3%
CAGR FY2015→2026
87%
Medicines Share
4
Product Categories Supplied
Slovenia is a significant market for Indian pharmaceutical exports — $156M in FY 2025–26, with 2.4× growth over the past decade. Medicines accounts for 87% of shipments. The compound annual growth rate since FY2015 stands at 8.3%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $136M (86.9%) Medicine Ingredients $18.9M (12.1%) Surgical & Hospital Supplies $804K (0.5%) Traditional & Herbal $719K (0.5%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Slovenia in the RBI overseas direct investment dataset (2011–2026).